Form 4: Chemours Co. Interim CFO Matthew Abbott Reports Stock Transaction
SEC Form 4 Filing
Interim CFO of Chemours Co., Matthew Abbott, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 1, 2024, Matthew Abbott, Interim CFO of Chemours Co., had shares withheld to cover tax obligations.
- A total of 4,415 shares of common stock were withheld at a price of $20.78 per share.
- Following the transaction, Abbott beneficially owns 29,931.4001 shares, including directly owned shares, restricted stock units, and dividend equivalent units.
- The transaction was exempt from Section 16(b) pursuant to Rule 16b-3.
- Abbott has a Power of Attorney designating Kristine Wellman and Nicole Perez Lengel to act on his behalf for SEC filings.
Sentiment
Score: 7
Explanation: The document is a standard SEC filing related to executive stock transactions, indicating a neutral sentiment. It reflects routine administrative processes.
Industry Context
This is a routine disclosure related to executive compensation and tax obligations, common among publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares withheld for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 2023/07/24 | Date of Power of Attorney execution. |
| 2024/03/01 | Date of stock transaction (share withholding for tax obligations). |
| 2024/03/05 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.